“Sudhin Biopharma Company became familiar with ARMI during several networking meetings at NIIMBL and heard your CTO, Thomas Bollenbach, speak about ARMI at the conference on the “Business of Regenerative Medicine” at U Penn Medicine last summer, 2018,” said Dhinakar Kompala, Founder & CEO, adding “We discussed the benefits of joining ARMI with Tom...